We have been interested in the application of readily available, fermentation-derived natural products as key building blocks for the preparation of natural product-like libraries rich in structural and stereochemical diversity. In this manuscript we describe the conversion of methyl nonactate, derived from nonactin, to a diversable scaffold characteristic of macrolide natural products. The synthesis features a key ring-closing metathesis reaction to form the macrocycle.
Introduction
The screening of small molecule collections to discover new medicinal chemistry leads is a critical step in the development of many therapeutic agents. 1 One of the major challenges is developing strategies to deliver new arrays of compounds for screenings that are structurally distinct from those types of compounds commonly found in HTS libraries. It is widely recognized that compounds more reminiscent of natural products are far less prevalent in typical screening libraries. 2 Whereas natural products are characterized by higher oxygen content, alicyclic systems and abundant stereogenic centers, typical screening compounds are much higher in nitrogen, planar aromatics and extremely limited stereochemical diversity. We have been interested in developing a strategy for the generation of highly complex compound arrays by integrating the ease and scalability of fermentation with the ability to conduct short, diversification sequences through reliable functional group interconversions. This type of strategy relies on simple fermentation technology to engender a high level of structural and stereochemical complexity in the compound series while routine synthetic transformations introduce key elements of diversity among the library members ( Figure 1 ). A cheap and readily available complex natural product is used as the point of departure for the preparation of key complex fragments that can be parlayed into a small group of diversable scaffolds using classical synthetic methods. A second round of synthesis would then be possible using a diversity-oriented manifold to elaborate the scaffolds into arrays of compounds having more natural product-like features than typical screening libraries.
One natural feedstock that we have found to have great utility in constructing new chemical entities is nonactin, a well known polyketide antibiotic that can be produced in significant quantities from Streptomyces griseus.
3 Previously, we had developed a method for the degradation of nonactin to give both enantiomers of methyl nonactate 1 and 2 as well as other isomeric units (Scheme 1). 4 Nonactin is the parent compound of a group of ionophore antibiotics known as the macrotetrolides. The 32-membered macrocyclic ring of nonactin is composed of two units of (+)-nonactate and two units of (-)-nonactate, alternately arrayed in a macrocycle, so that the molecule has overall S4 symmetry and is achiral. Because nonactin contains an equal number of (+)-and (-)-nonactate residues, exhaustive methanolysis of nonactin (Scheme 1) delivers racemic methyl nonactate.
5 A biotransformation-based kinetic resolution can be initiated by exposure of the racemate to Rhodococcus erythropolis under aerobic conditions to produce methyl (-)-8-ketononactate and unreacted methyl (+)-nonactate. The ketoester can then be re-reduced by Rhodococcus erythropolis under anaerobic conditions to give methyl (-)-nonactate. Other nonactate scaffolds can be obtained by various stereoselective transformations. It is noteworthy that compounds constructed from these six fragments would yield a library rich in stereochemical and not just structural diversity. Constructing novel chemotypes from nonactate is a priority as it allows the expansion of these natural product-like libraries into additional areas of unexplored chemical space. This manuscript details our efforts to construct new diversable scaffolds reminiscent of macrolide topology. Macrolide natural products represent a large classification of bioactive secondary metabolites that span a range of activities such as antibiotic, anticancer and immunosupressive properties. Interestingly, it was recently demonstrated that an erythromycin derivative emerges as hit form a library screen for non-peptide LHRH antagonists, thus illustrating that activities distinct from the natural function can emerge with structurally related congeners. 
Results and Discussion
The design for a macrolide-like library from nonactate suggested an advanced scaffold that maintains several sites for diversification about the macrocycle while the embedded tetrahydrofuran unit imparts rigidity to the core structure, a beneficial effect seen with the third-generation 
Scheme 3
With the four RCM precursors in hand (each as a mixture of diastereomers), we set out to determine optimal conditions for the key ring-closing olefin metathesis reaction. Intramolecular RCM reaction of 8a was initially carried out at three different concentrations (10, 5 and 2.5 mM). Pleasingly, the desired product 9a was isolated as a 1:5 mixture of cis:trans isomers and in 81% yield at 2.5 mM. Running the reaction at the higher concentrations produced a dramatic diminution in yield an as such, all future RCM experiments were run only at 2.5 mM. From the distribution of products, it appeared that all of the diastereomers in the mixture cyclized with similar facility. Diesters 8b and 8c behaved similarly to 8a and were cyclized into the corresponding macrocycles 9b and 9c in similar yields. However, subjecting 8d to the same set of conditions resulted only in extensive decomposition of the starting material. By switching to Grubbs'-Hoveyda 2nd generation catalyst, increasing the catalyst load to 20 mol% and increasing the reaction time to 5 days, we were able to isolate macrocycle 9d, albeit in lower yield
The result of these initial model cyclizations revealed that these 14-membered macrocycles could be formed directly by metathesis of an acyclic diene in reasonable yield and that the cyclization would be most effective with one pendant group in an allylic position. With the success of this initial model series, we set out to prepare more functionalized scaffolds as single enantiomers to be utilized in the generation of macrolide-like libraries. Of the two allylic positions that are installed on the nonactin scaffold we elected to introduce a diversable position at C5 since we envision that the carbonyl functionality at C1 will allow introduction of C2 diversity after formation of the nonactolide. This pendant functionality creates an additional stereogenic center in the scaffold and requires the preparation of the fragment in non-racemic form. We were attracted to the method developed by Trost 12 for the asymmetric opening of vinyl oxiranes (Scheme 4).
Scheme 4
Commercially available butadiene monoxide 10 was opened with p-methoxybenzyl alcohol in the presence of a palladium source and either R,R-or S,S-DACHN ligands to give the enantiomeric alcohols 11 and 12. Separation of the alcohols from residual p-methoxybenzyl alcohol proved difficult so the crude mixtures were converted to the corresponding OTBDMS ethers under standard conditions. After purification, desilylation could be effected to regenerate the pure alcohols and the specific optical rotations of compounds 11 and 12 were determined to be [α] alcohols 13 and 14 were best obtained by deprotection of the PMB groups with trifluoroacetic acid as the typical DDQ deprotection was problematic due to an inability to separate the product from pmethoxybenzaldehyde. With the enantiomerically enriched allylic alcohols in hand, elaboration of a non-racemic nonactate fragment was expected to follow from prior model studies (Scheme 5).
Scheme 5
Surprisingly, the secondary alcohols 13 and 14 turned out to be less reactive than the allylic alcohols used in the prior studies and could not be coupled under the previously developed conditions. Converting carboxylic acid (-)-15 into the acid chloride was necessary to facilitate ester formation to give 16a/b which was accompanied by partial deprotection of the OTBS group. Heating an ethanolic solution of the reaction products with pyridinium p-toluenesulfonate completed removal of the OTBS group to give 17a/b. Unexpectedly, acylation of the secondary alcohol of 17a/b with either vinyl acetyl chloride or vinyl acetic acid and a variety of coupling agents proved unsuccessful. Since the secondary hydroxyl group and the allylic substituent are separated by 10 atoms in both 7 and 17, a correlation between the size of allylic substituents and the reactivity of the secondary hydroxyl group was unanticipated. One possible explanation for this phenomenon is based on intramolecular hydrogen bond formation between the hydroxyl group and the oxygen atom of the tetrahydrofuran moiety. This interaction could lead to certain conformational changes that might bring the allylic side arm closer to the C8 hydroxyl group (nonactate numbering). In this case, the larger allylic substituents of alcohols 17a/b may shield the C8 hydroxyl, resulting in lower than expected reactivity. Because of this unexpected reactivity, the scaffold was revised to incorporate a C8 nitrogen in place of the oxygen atom to increase the nucleophilicity and hopefully result in productive acylation chemistry (Scheme 6). 
Scheme 6
Methyl nonactate (-)15 was converted to the corresponding azide through the intermediacy of the mesylate. Surprisingly, under these fairly standard conditions, racemization of the C8-stereogenic center was observed, leading to an inseparable mixture of azides 18. We elected to continue on with this mixture to fully evaluate the design and hopefully separate the diastereomers at a later point in the synthesis. Alkaline hydrolysis of 18 afforded carboxylic acids 19 in nearly quantitative yield, which were elaborated to esters 20a/b as previously described via an acid chloride intermediate. Reduction of the azide moiety with triphenylphosphine occurred smoothly and pleasingly the crude amines could converted into amides 21a and 21b by mixed anhydride acylation.
13 as a prelude to the key RCM reaction (Scheme 7).
Scheme 7
Although reaction times and catalyst loading had to be increased compared to the conditions used to cyclize diesters 8a-d, we were able to isolate 14-membered macrocyclic compounds 22a/b and 23a/b, in reasonable yields. In addition, it was gratifying to find that we could affect separation of the two C8-epimers by simple chromatography. The identity of each isomer was assigned by NMR analysis of NOESY correlations between the α-amino proton and protons on the tetrahydorfuran ring and allylic protons in the macrocycle. As before, the trans isomer predominates (>5:1 ratio by NMR analysis of the crude mixture) with the minor cis isomer being simply removed by chromatography. Final deprotection of tert-butyldiphenylsilyl ethers was achieved by using a 70 % solution of hydrofluoric acid in pyridine to produce the scaffolds 24a, 24b, 25a and 25b. These four enantiomerically pure scaffolds contain up to four sites for diversification including the activate methylene, alkene and the pendant primary alcohol.
Conclusions
As part of a long term program aimed at the development of natural product-like libraries derived from natural feedstocks, we have focused on the development of high complexity scaffolds to be used in library synthesis. In this manuscript, we report on studies aimed at the development of macrolide-like scaffolds derived form various isomers of nonactate. The resultant "nonactolides" will represent a scalable and economical collection of diversable scaffolds rich in stereochemical as well as substituent diversity. Use of a highly effective RCM reaction on a nonactate-derived diene delivered the scaffolds with up to 4 positions that can be used to introduce diversity into the structure. The effectiveness of RCM reactions was essentially independent of the configuration of the stereogenic centers present in diene but was sensitive to the presence of substituents in the allylic position. Current efforts are focused on the diversification of the nonactolide scaffolds to produce natural product-like libraries.
Experimental Section (±)-O-(tert-Butyldimethylsilyl)nonactic acid allyl ester (6a). To a solution of 1.56 g (4.9 mmol, 1.0 eq) of carboxylic acid 5 in 5 mL of CH 2 Cl 2 were added 2.13 g (10.3 mmol, 2.1 eq) of 1,3-dicyclohexylcarbodiimide, 0.44 mL (6.4 mmol, 1.3 eq) of allyl alcohol and a catalytic amount of 4-(dimethylamino)-pyridine. The resulting mixture was stirred at room temperature for 16 h. After evaporation of the solvent under reduced pressure the crude product was purified by flash chromatography (SiO 2 , 87 g, 1% ether/pentane → 2% ether/pentane) giving ester 6a as a colorless oil (1.31 g, 74%) : TLC R f = 0.33 (5% ether/pentane); IR (neat, KBr, cm -1 ) 2957 (neat, KBr, cm -1 ) , 2930 (neat, KBr, cm -1 ) , 2883 (neat, KBr, cm -1 ) , 2856 (neat, KBr, cm -1 ) , 1740 (neat, KBr, cm -1 ) , 1462 (neat, KBr, cm -1 ) , 1377 (neat, KBr, cm -1 ) , 1256 (neat, KBr, cm -1 ) , 1153 (neat, KBr, cm -1 ) , 1070 1 H NMR (500 MHz, CDCl 3 ) δ 5.92 (ddt, J = 17. 1, 10.5, 5.6 Hz, 1H), 5.32 (ddd, J = 17.1, 3.0, 1.5 Hz, 1H), 5.21 (ddd, J = 10.5, 3.0, 1.5 Hz, 1H), 4.62 (ddt, J = 13.4, 5.6, 1.4 Hz, 1H), 4.56 (ddt, J = 13.4, 5.6, 1.4 Hz, 1H), 3H) 7, 132.5, 118.0, 80.4, 76.4, 66.3, 65.1, 46.2, 45.8, 31.5, 28.9, 26.1, 24.8, 18.2, 13.6, -4.4, -4.7 (±)-O-(tert-Butyldimethylsilyl)nonactic acid 3-buten-2-olyl ester (6b). To a solution of 0.0624 g (0.20 mmol, 1.0 eq) of carboxylic acid 5 in 2 mL of CH 2 Cl 2 were added 0. 093 g (0.49 mmol, 2.5 eq) of EDC .
HCl, and 0.101 g (0.83 mmol, 4.2 eq) of 4-(dimethylamino)pyridine. The resulting mixture was stirred at room temperature for 1 h. Then, 44 mL (0.49 mmol, 2.5 eq) of 3-buten-2-ol was added, and the reaction mixture was stirred at room temperature for another 16 h. After evaporation of the solvent under reduced pressure, 3 mL of ether was added to the crude product, followed by 1 mL of ice-cold HCl (1.0 M). The resulting emulsion was shaken vigorously, organic layer was separated and the aqueous layer was extracted with ether (3*2mL). The combined organic extracts were dried over MgSO 4 174.3, 174.2, 138.0, 115.7, 115.5, 80.4, 80.3, 76.4, 70.8, 70.7, 66.4, 66.3, 46.3, 46.2, 45.9, 45.8, 31.6, 28.7, 26.1, 24.8, 20.1, 20.0, 18.2, 13.5, 13.4, -4.4, -4.7 
General procedure for TBS deprotection
To a 0.1 M solution of either TBS protected alcohol 6a or 6b (1.0 eq) in THF was added a solution of HF in pyridine (20.0 eq, 70% by weight) in one portion. The resulting solution was stirred at room temperature for 18 h until TLC showed no starting material. Methoxytrimethylsilane (60.0 eq) was added and the reaction mixture was stirred vigorously for 10 min to neutralize the excess of HF. After evaporation of the solvent under reduced pressure the crude product was purified by flash chromatography (SiO 2 , 1:50 ratio of crude product to silica gel).
(±)-Nonactic acid allyl ester (7a).
Using the general procedure as described above, TBS-protected alcohol 6a (0.083 g, 0.23 mmol) was reacted to give alcohol 48a (0.048 g, 86%) as a colorless oil after flash chromatography (SiO 2 , 3 g, 20% ether/pentane → 25% ether/pentane): TLC R f = 0.21 (40% ether/pentane); IR (neat, KBr, cm -1 ) 3429 (broad), 2968, 2937, 2360, 2341, 1738, 1462, 1456, 1377, 1271, 1250, 1186, 1159, 1090, 1059, 935 6, 132.3, 118.3, 81.1, 77.3, 65.3, 65.2, 45.5, 43.0, 30.7, 28.9, 23.4, 13.7 1, 137.9, 137.8, 116.0, 115.8, 81.2, 81.1, 77.3, 77.2, 71.2, 71.1, 65.4, 45.6, 43.1, 42.9, 30.8, 30.7, 28.9, 28.8, 23.4, 23.3, 20.1, 20.0, 13.6, 13.5; 13 C NMR (125 MHz, C 6 D 6 ) δ (mixture) 173.9, 173. 8, 138.7, 138.6, 115.9, 115.8, 81.6, 81.4, 77.6, 77.5, 71.3, 71.2, 65.4, 46.1, 44.2, 44.0, 31.3, 31.2, 29.1, 29.0, 24.2, 24.1, 20.4, 20.3, 13.9, 13.8; 13 C NMR (125 MHz, C 6 D 6 ) δ 173. 6, 173.5, 138.4, 138.3, 115.6, 115.5, 81.3, 81.1, 77.2, 77.1, 71.0, 70.9, 65.1, 45.8, 45.7, 43.8, 43.7, 31.0, 30.9, 28.8, 28.7, 23.9, 23.8, 20.1, 20.0, 13.6, 13.5 8, 132.2, 130.4, 118.2, 117.9, 80.4, 76.2, 69.5, 64.9, 45.4, 42.4, 39.4, 31.2, 28.4, 20.5, 13.3 General esterification procedure using acid chlorides To a 0.2 M solution of either alcohol 7a or alcohol 7b (1.0 eq) in anhydrous CH 2 Cl 2 cooled to 0 o C were added N-methylmorpholine (3.0 eq), either vinylacetic acid chloride or 2-methyl-3-butenoic acid chloride (2.0 eq) and a catalytic amount of 4-(dimethylamino)pyridine. The resulting mixture was stirred at 0 o C for 30 min and then at room temperature for 1-2 hr. After evaporation of the solvent under reduced pressure, the crude product was dissolved in an ice-cold 3:1 emulsion of ether and 1.0 M HCl (3.0 eq). The resulting emulsion was shaken vigorously, organic layer was separated and the aqueous layer was extracted with ether. The combined organic extracts were dried over MgSO 4 . After evaporation of the solvent under reduced pressure, the crude product was purified by flash chromatography (SiO 2 , 1:100 ratio of crude product to silica gel).
2-Methyl-but-3-enoic acid 2-[5-(1-allyloxycarbonylethyl)tetrahydrofuran-2-yl]-1-methyl-ethyl ester (8b).
Using the general procedure as described above, alcohol 7a (0.119 g, 0.49 mmol) was reacted to give 0.142 g (88%) of the diester 8b as a colorless oil (mixture of diastereomers) after flash chromatography (SiO 2 , 25 g, 5% ether/hexanes → 7% ether/hexanes): TLC R f = 0.31 (20% ether/hexanes); IR (neat, KBr, cm -1 ) 2978, 2939, 2880, 1738, 1732, 1639, 1456, 1377, 1327, 1250, 1188, 1165, 1090, 1059, 993 4, 173.8, 173.7, 137.4, 137.3, 132.3, 118.0, 115.7, 115.6, 80.5, 80.4, 76.4, 76.3, 69.5, 69.4, 65.0, 45.5, 43.9, 43.8, 42.5, 31.4, 28.5, 20.6, 20.5, 16.7, 16.6, 13.4 
But-3-enoic acid 1-methyl-2-{5-[1-(1-methyl-allyloxycarbonyl)-ethyl]-tetrahydrofuran-2-yl}-ethyl ester (8c).
Using the general procedure as described above, alcohol 7b (0.009 g, 0.04 mmol) was reacted to give 0.013 g (86%) of the diester 8c as a colorless oil (mixture of diastereomers) after flash chromatography (SiO 2 , 2 g, 5% ether/pentane): TLC R f = 0.34 (20% ether/pentane); IR (neat, KBr, cm -1 ) 2978, 2935, 2878, 2359, 2343, 1738, 1732, 1647, 1458, 1377, 1256, 1178, 1090, 1055, 993, 922 1, 171.1, 137.9, 137.8, 130.6, 118.5, 115.8, 115.7, 80.6, 80.5, 76.5, 76.4, 70.9, 69.9, 69.8, 45.7, 42.6, 42.5, 39.6, 31.5, 28.6, 28.5, 20.8, 20.0, 19.9, 13.4, 13.3 174.0, 137.9, 137.5, 115.8, 115.7, 80.5, 76.5, 70.9, 69.7, 45.7, 44.0, 42.6, 31.6, 28.5, 20.7, 20.0, 16.8, 13.3; 13 C NMR (125 MHz, C 6 D 6 ) δ (major) 173. 4, 173.2, 138.4, 138.1, 115.5, 115.4, 80.8, 76.4, 70.7, 69.5, 45.8, 44.3, 42.9, 31.6, 28.5, 20.8, 20.0, 16.9, 13 8, 170.7, 126.4, 126.3, 82.2, 74.5, 68.7, 62.4, 46.6, 39.6, 38.5, 32.1, 29.1, 18.3, 14.6; δ (minor) 175.7, 170.6, 130.6, 126.0, 82.3, 75.1, 68.2, 58.1, 46.1, 38.7, 33.9, 31.4, 29.2, 19.3, 14.4 1, 136.3, 135.8, 133.8, 133.7, 130.9, 129.7, 129.6, 129.3, 127.7, 118.1, 113.8, 80.9, 70.4, 66.9, 55.3, 27.0, 19.4; [α] 
(2R)-tert-Butyl-[2-(4-methoxybenzyloxy)but-3-enyloxy]diphenylsilane.
Using the general procedure as described above, (2R)-2-(4-methoxy-benzyloxy)-but-3-en-1-ol (0.5389 g, 2.59 mmol) was reacted to give a colorless oil (0.698 g, 79% over 2 steps) after chromatography: TLC R f = 0.20 (10% ether/hexanes); IR (neat, KBr, cm -1 ) 2957, 2932, 2858, 1612, 1514, 1464, 1427, 1248, 1113, 1088 2, 136.3, 135.8, 133.8, 133.7, 131.0, 129.7, 129.7, 129.4, 127.7, 118.2, 113.8, 80.9, 70.5, 67.0, 55.4, 27.0, 19.4; [α] General PMB deprotection procedure Ethers (1.0 eq) was dissolved in ice-cold 10% (by volume) solution of trifluoroacetic acid in CH 2 Cl 2 (16.5 eq). The cooling bath was removed and the resulting solution was stirred at room temperature for 15 min. Then saturated aqueous NaHCO 3 (2.8 times the volume of the reaction mixture) was added, the organic layer was separated and the aqueous layer was extracted with CH 2 Cl 2 . The combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. The crude product was purified by flash chromatography (SiO 2 , 1:100 ratio of the crude product to silica gel, 2% ether/pentane → 3% ether/pentane). (2S)-1-(tert-Butyldiphenylsilanyloxy)but-3-en-2-ol (13). Using the general procedure as described above, (2S)-tert-butyl-[2-(4-methoxy-benzyloxy)-but-3-enyloxy]-diphenyl-silane (0.403 g, 0.90 mmol) was reacted to give 13 as a colorless oil (0.214 g, 73%) after chromatography: TLC R f = 0.45 (20% ether/pentane); IR (neat, KBr, cm -1 ) 3443 (broad), 2959, 2930, 2858, 1472, 1427, 1113, 1070, 989, 8, 135.7, 135.6, 133.2, 133.1, 130.0, 127.9, 116.6, 73.1, 67.8, 27.0, 19.4 7, 135.7, 135.6, 133.3, 133.2, 130.0, 127.9, 116.7, 73.2, 67.8, 27.0, 19.4; [α] 
2-[5-(2-Azidopropyl)tetrahydrofuran-2-yl]propionic acid methyl ester (18).
Methyl (-)-nonactate (-)-15 (0.821g, 3.8 mmol, 1.0 eq) and triethylamine (1.1 mL, 7.6 mmol, 2.0 eq) were dissolved in 19 mL of anhydrous CH 2 Cl 2 and cooled to 0 o C. Mesyl chloride (0.38 mL, 4.9 mmol, 1.3 eq) was added dropwise, and the resulting solution was stirred at 0 o C under argon for 2 hr.
Then, it was poured into ice-cold HCl (1.0 M, 7.6 mL) and stirred vigorously. The aqueous layer was separated and extracted with CH 2 Cl 2 (3*8 mL). The combined organic extracts were washed with saturated NaHCO 3 , dried over MgSO 4 and concentrated to give crude mesylate. A solution of the crude mesylate in 12.7 mL of DMF was placed in a sealed tube equipped with a stir bar, NaN 3 (0.493 g, 7.6 mmol, 2.0 eq) was added, and the resulting mixture was stirred at 50 o C under argon for 18 h. The reaction mixture was diluted with 140 mL of water, and poured into 200 mL of diethyl ether. The organic layer was separated, and the aqueous layer was extracted with ether (3*150 mL). The combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure to give 1.05 g of the crude azide. Flash chromatography (SiO 2 , 100 g, 4% ether/pentane → 10% ether/pentane) afforded 0.8690 g (95%) of the azidoester 56 as a colorless oil (mixture of diastereomers): TLC R f = 0.19 (10% ether/pentane); IR (neat, KBr, cm -1 ) 2974, 2949, 2880, 2359, 2341, 2102, 1748, 1460, 1435, 1379, 1331, 1256, 1200, 1165, 1090, 1061; 1 H NMR (500 MHz, CDCl 3 ) δ (mixture) 3.98 (qd, J = 6.9, 1.8 Hz, 1H), 1H) 2, 80.7, 76.3, 55.4, 51.6, 45.4, 42.1, 31.1, 28.5, 19.3, 13.5 
2-[5-(2-Azidopropyl)tetrahydrofuran-2-yl]propionic acid (19).
To a solution of the azidoester 18 (0.869 g, 3.6 mmol, 1.0 eq) in 18 mL of THF and 6 mL of MeOH was added 36 mL of KOH (1.0 M). The reaction mixture was stirred at room temperature for 20 h. Then, it was concentrated under reduced pressure, partially dissolved in ether and treated with 18 mL of ice-cold HCl (2.0 M). After vigorous stirring the organic layer was separated and the aqueous layer was extracted with ether (3*20 mL). The combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure to give 0.792 g (97%) of carboxylic acid 19 as a colorless oil (mixture of diastereomers), which was used without further purification. TLC R f = 0.26 (60% ether / pentane); IR (neat, KBr, cm -1 ) 3100 (broad), 2974, 2920, 2359, 2341, 2102, 1711, 1462, 1379, 1250, 1090, 667 General esterification procedure A 0.4 M solution of 8-azido-nonactic acid 19 (1.6 eq) in anhydrous benzene was placed in a twonecked flask equipped with a stir bar and a drying tube. Oxalyl chloride (2.8 eq) was added dropwise via syringe, and the reaction mixture was stirred at room temperature until bubbling completely ceased (approx. 6 h). Benzene and the excess of oxalyl chloride were removed under reduced pressure leaving crude acid chloride as a yellow oil, which was dissolved in anhydrous CH 2 Cl 2 to make a 1.0 M solution of 8-azidononactic acid chloride. A 0.2 M solution of monoprotected diol 13 or 14 (1.0 eq) in CH 2 Cl 2 was cooled down to 0 o C and N-methylmorpholine (2.0 eq) was added in one portion followed by a dropwise addition of a freshly prepared 1.0 M solution of the acid chloride (1.6 eq) and a catalytic amount of DMAP. Reaction mixture was stirred at 0 o C for 1 h and another 6 h at room temperature under argon. After evaporation of the solvent under reduced pressure, the residue was re-dissolved in an ice-cold 3:1 emulsion of ether and 1.0 M HCl (2.0 eq). After vigorous stirring the organic layer was separated and the aqueous layer was extracted with ether. The combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. The crude product was purified by flash chromatography (SiO 2 , 1:85 ratio of the crude product to silica gel, 3% ether/pentane → 5% ether/pentane). 2-[5-(2-Azidopropyl)tetrahydrofuran-2-yl]propionic acid 1-(tert-butyldiphenylsilanyloxymethyl)allyl ester (20a). Using the general procedure as described above, (2S)-1-(tert-butyldiphenylsilanyloxy)-but-3-en-2-ol (0.497 g, 1.52 mmol) was reacted to give 0.722 g (88%) of the azidoester 20a as a colorless oil (mixture of diastareomers) after chromatography: TLC R f = 0.19 (10% ether/pentane); IR (neat, KBr, cm -1 ) 2959, 2932, 2858, 2100, 1738, 1427, 1252, 1188, 1165, 1113, 1090, 997, 935 ; 1 H NMR (500 MHz, CDCl 3 ) δ (mixture) 4H), 6H), 1H), 5.43 (ddd, J = 17.1, 11.1, 5.9 Hz, 1H), 5.32 (dd, J = 17.3, 1.0 Hz, 1H), 5.20 (ddd, J = 10.8, 2.7, 1.3 Hz, 1H), 4.07 (ddd, J = 20.0, 14.6, 7.1 Hz, 1H), 1H), 1H), 1H), 1H), 2.59 (td, J = 14.6, 7.3 Hz, 1H) , 2.07 -1.89 (m, 2H), 1H), 1H), 2H), 1.23 (dd, J = 12.0, 6.5 Hz, 3H), 1.13 (dd, J = 10.3, 7.1 Hz, 3H), 1.04 (s, 9H) ; 13 C NMR (125 MHz, CDCl 3 ) δ (mixture) 174.3, 173.8, 135.8, 135.7, 133.7, 133.6, 133.5, 133.4, 129.9, 129.8, 127.8, 117.9, 117.8, 80.7, 80.3, 76.3, 76.2, 75.1, 75.0, 65.5, 65.4, 55.4, 45.6, 45.5, 42.1, 42.0, 31.3, 28.4, 28.2, 26.9, 26.8, 19.4, 19.2, 13.3, 13 2932, 2858, 2100, 1736, 1427, 1250, 1188, 1163, 1113, 1090, 997, 935 ; 1 H NMR (500 MHz, CDCl 3 ) δ (mixture) 4H), 6H), 5.81 (dq, J = 10.7, 5.8 Hz, 1H), 1H), 5.32 (d, J = 17.3 Hz, 1H), 5.20 (dd, J = 10.7, 1.2 Hz, 1H), 1H), 1H), 1H), 3.70 (ddd, J = 10.7, 9.1, 4.5 Hz, 1H), 3.55 (qd, J = 13.4, 6.8 Hz, 1H) , 2.59 (dp, J = 14.2, 7. 3, 173.8, 135.8, 135.7, 133.7, 133.6, 133.5, 133.4, 129.9, 129.8, 127.8, 117.9, 117.8, 80.7, 80.3, 76.2, 75.1, 75.0, 65.5, 65.4, 55.4, 45.5, 42.1, 42.0, 31.3, 28.4, 28.2, 26.9, 26.8, 19.4, 19.2, 13.4, 13 
General procedure for amide preparation
To a 0.17 M solution of azidoester 20a or 20b (1.0 eq) in 5:1 mixture of THF and water was added triphenylphosphine (1.5 eq). The reaction mixture was stirred at room temperature for 48 h. The solvent was removed under reduced pressure, the residue was dissolved in CH 2 Cl 2 , dried over Na 2 SO 4 and concentrated under reduced pressure. 0.1 M solution of the crude amine in anhydrous THF was cooled down to 0 o C. N-methylmorpholine (3.0 eq) was added followed by a dropwise addition of 0.19 M solution of the mixed vinylacetic acid / trimethylacetic acid anhydride in THF (2.0 eq). The reaction mixture was stirred at 0 o C for 1 hr and at room temperature for another 16 h under argon. After evaporation of the solvent under reduced pressure, the residue was re-dissolved in an ice-cold 3:1 emulsion of ether and 1.0 M HCl (3.0 eq). After vigorous stirring the organic layer was separated, and the aqueous layer was extracted with ether. The combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. The crude product was purified by flash chromatography (SiO 2 , 1:100 ratio of the crude product to silica gel, 25% ether/pentane → 30% ether/pentane). 2-[5-(2-But-3-enoylaminopropyl)tetrahydrofuran-2-yl]propionic acid 1-(tertbutyldiphenylsilanyloxymethyl)allyl ester (21a). Using the general procedure as described above, azidoester 20a (0.722 g, 1.35 mmol) was reacted to give 0.639 g (82%) of esteramide 21a as a colorless oil (mixture of diastereomers) after chromatography: TLC R f = 0.27 (60% ether/pentane); IR (neat, KBr, cm -1 ) 3294 (broad), 3072, 2961, 2930, 2858, 1736, 1651, 1541, 1462, 1427, 1258, 1190, 1113, 1088, 997, 922 ; 1 H NMR (500 MHz, CDCl 3 ) δ (mixture) 7.66 (dt, J = 7.9, 1.3 Hz, 4H), 6H), 1H), 1H), 1H), 1H), 5.31 (ddt, J = 17.3, 8.2, 1.2 Hz, 1H), 3H), 4.05 (dq, J = 12.0, 7.2 Hz, 1H), 1H), 1H), 3.77 (ddd, J = 10.4, 6.7, 3.6 Hz, 1H), 3.71 (ddd, J = 10.7, 6.1, 4.5 Hz, 1H) , 2.93 (dd, J = 7.1, 1.2 Hz, 2H), 2.59 (dp, J = 10.2, 7. 0, 173.7, 170.4, 135.6, 135.5, 133.5, 133.4, 133.3, 133.2, 131.8, 131.7, 129.8, 129.7, 127.7, 119.1, 119.0, 118.0, 117.8, 80.7, 80.4, 77.8, 77.7, 75.0, 74.9, 65.4, 65.3, 45.4, 45.2, 44.7, 44.6, 42.5, 42.4, 41.8, 31.7, 31.6, 28.1, 28.0, 26.8, 26.7, 21.8, 19.3, 13.4, 13 1, 173.7, 170.4, 135.7, 135.6, 133.7, 133.5, 133.4, 133.3, 131.8, 131.7, 129.9, 129.8, 127.8, 119.3, 119.2, 118.1, 117.9, 80.7, 80.5, 77.9, 77.8, 75.1, 75.0, 65.5, 65.4, 45.5, 45.3, 44.8, 44.7, 42.5, 42.4, 41.9, 31.8, 31.7, 28.2, 28.1, 26.9, 26.8, 21.9, 19.3, 13.5, 13 
General procedure for ring-closing metathesis
To a 0.0015 M solution of esteramide 21a or 21b (1.0 eq) in anhydrous CH 2 Cl 2 Grubbs'-Hoveyda 2nd generation catalyst (15 mol%) was added. The reaction mixture was stirred at room temperature under argon for 72 h until TLC showed no starting material. Ethyl vinyl ether (15.0 eq) was added and the reaction mixture was stirred vigorously for 30 min. Evaporation of the solvent gave the crude product as a mixture of 2 diastereomers that were separated by fllash chromatography (SiO 2 , 1:100 ratio of the crude product to silica gel, 27% ether/pentane → 35% ether/pentane). In order to remove ruthenium byproducts, each diastereomer was dissolved in minimal amount of ether and treated with activated carbon (Darco® G-60, 100 mesh, powder, 10 wt. eq). 4, 170.1, 135.7, 135.6, 133.4, 133.3, 132.0, 129.9, 129.8, 129.7, 127.8, 83.6, 79.4, 72.7, 64.7, 53.5, 47.7, 45.8, 42.3, 40.6, 38.4, 32.0, 29.0, 26.8, 21.5, 19.3, 14 3, 170.3, 135.6, 135.5, 133.3, 133.2, 131.6, 129.9, 129.8, 128.8, 127.8, 127.7, 82.1, 80.2, 74.2, 64.9, 53.5, 48.7, 47.5, 41.9, 40.2, 31.8, 28.7, 26.7, 21.7, 19.23, 13.9; [α] Using the general procedure as described above, esteramide 21b (0.6169 g, 1.07 mmol) was reacted to give esteramide 23a (0.037 g, 50%) and 23b (0.023 g, 32%) as colorless oils after chromatography and activated carbon treatment: (1R,2R,5R,11S,13S)-5-(tert-Butyldiphenylsilanyloxymethyl)-2,11-dimethyl-4,16-dioxa-10-azabicyclo[11.2.1]hexadec-6-ene-3,9-dione (23a). TLC R f = 0.25 (60% ether/pentane); IR (neat, KBr, cm -1 ) 3394, 2961, 2932, 2858, 1732, 1661, 1516, 1462, 1427, 1371, 1267, 1190, 1169, 1134, 1113, 1072, 1030, 976, 824, 739, 704 175.5, 170.3, 135.7, 133.4, 132.1, 129.9, 127.8, 125.4, 83.7, 79.5, 72.4, 64.7, 47.8, 45.9, 42.4, 40.6, 32.1, 29.1, 26.9, 21.6, 19.4, 14. 2959, 2932, 2858, 2361, 2341, 1734, 1663, 1522, 1458, 1427, 1250, 1113, 1055, 1030, 976, 744, 704, 4, 170.4, 135.7, 135.6, 133.4, 133.3, 131.7, 129.9, 129.8, 128.9, 127.9, 127.8, 82.2, 80.3, 74.3, 65.0, 48.8, 47.6, 42.0, 40.3, 31.9, 28.8, 26.8, 21.8, 19.4, 14. 
General procedure for TBDPS deprotection
To a 0.1 M solution of TBDPS protected alcohol (1.0 eq) in THF was added a solution of HF in pyridine (20.0 eq, 70% by weight) in one portion. The resulting solution was stirred at room temperature for 72 h until TLC showed no starting material. Methoxytrimethylsilane (60 eq) was added, and the reaction mixture was stirred for 10 min to neutralize the excess of HF. After evaporation of the solvent under reduced pressure, the crude product was purified by flash chromatography (SiO 2 , 1:50 ratio of crude product to silica gel, 60% ether/hexanes → 100% ether).
(1R,2R,5S,11S,13S)-5-Hydroxymethyl-2,11-dimethyl-4,16-dioxa-10-azabicyclo[11.2.1]hexadec-6-ene-3,9-dione (24a). Using the general procedure as described above, compound 22a (0.141 g, 0.26 mmol) was reacted to give alcohol 24a as a colorless oil (0.065 g, 82%) after flash chromatography (SiO 2 , 7 g, 60% ether/hexanes → 80% ether/hexanes): TLC R f = 0.16 (100% ether); IR (neat, KBr, cm -1 ) 3383, 3304 (broad), 2968, 2935, 2876, 1728, 1651, 1531, 1454, 1373, 1269, 1192, 1167, 1097, 1070, 1038 175.5, 170.3, 131.9, 130.0, 83.6, 79.5, 72.9, 63.5, 47.8, 45.7, 42.2, 40.5, 32.0, 29.0, 21.5, 14.4; [α] 3377, 2966, 2934, 2876, 1732, 1645, 
